Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 63 clinical trials
Featured trial
A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Patients with Moderately to Severely Active Ulcerative Colitis (UC)

A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Patients with Moderately to Severely Active Ulcerative Colitis (UC)

  • 106 views
  • 08 Nov, 2020
  • 1 location
Featured trial
A Double-Blind, Randomized, Multicenter Study of Higher Versus Standard Adalimumab Dosing Regimens for Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis

A Double-Blind, Randomized, Multicenter Study of Higher Versus Standard Adalimumab Dosing Regimens for Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative

  • 90 views
  • 25 Mar, 2021
  • 1 location
Featured trial
Ulcerative Colitis

Ulcerative Colitis

  • 28 views
  • 08 Nov, 2020
  • 1 location
A Study to Compare the Response to Treatment With Abatacept vs Adalimumab, on Background Methotrexate, in Adults With Early, Seropositive, and Shared Epitope-positive Rheumatoid Arthritis and an Inadequate Response to Methotrexate

The purpose of this study is to evaluate the superiority in efficacy of abatacept compared with adalimumab, on background methotrexate, in adults with early, seropositive, and shared epitope

methotrexate
abatacept
adalimumab
rheumatoid factor
DMARD
  • 0 views
  • 29 Jul, 2022
  • 63 locations
Adalimumab vs. Conventional Immunosuppression for Uveitis Trial (ADVISE)

immunosuppression. Based upon preliminary data, adalimumab, a fully-human, anti-TNF-α monoclonal antibody, now US FDA-approved for uveitis treatment, may be a superior corticosteroid-sparing agent than conventional

tumor necrosis factor
methotrexate
adalimumab
small molecule
cyclosporine
  • 140 views
  • 14 Jul, 2022
  • 18 locations
Adalimumab Plus Methotrexate for the Treatment of Pediatric Uveitis

The aim of this study is to determine the efficacy and safety of ADA plus MTX for the treatment in non-infectious pediatric panuveitis.

methotrexate
adalimumab
panuveitis
  • 0 views
  • 09 Jan, 2022
  • 1 location
Combination of Baricitinib and Adalimumab in Rheumatoid Arthritis (CRI-RA)

, reversible and competitive inhibitor of Janus kinases (Jaki). This treatment is efficient in a number of therapeutic scenarios in RA and showed a clinical superiority over adalimumab in one RCT (RA-BEAM

tumor necrosis factor
methotrexate
tofacitinib
rituximab
adalimumab
  • 0 views
  • 15 Mar, 2022
  • 6 locations
Rotation or Change of Biotherapy After TNF Blocker Treatment Failure for Axial Spondyloarthritis (ROC-SPA)

rheumatoid arthritis. Etanercept is a fusion protein with TNF receptor type II p75 and IgG1 Fc fragment, whereas adalimumab, infliximab, and golimumab are monoclonal antibodies. Certolizumab is a fusion

biological therapy
steroidal anti-inflammatory drugs
il-23
NSAID
DMARD
  • 17 views
  • 27 Feb, 2022
  • 11 locations
BARIcitinib Cognitive Emotional and Neural signaTuRE (BARICENTRE)

efficient treatment in placebo-controlled trials, and compared to the reference treatment with TNF inhibitor (adalimumab). Its efficacy has been reported on the inflammatory parameters, but more importantly

  • 0 views
  • 24 Apr, 2022
  • 1 location
Clinical Study of Cord Blood Mononuclear Cells on Treatment of Hormone-resistant or Hormone-dependent Ulcerative Colitis

This study conducted a systematic clinical observation of the clinical efficacy of UCB-MNCs in the treatment of hormone-resistant or hormone-dependent ulcerative colitis, in order to observe its clinical safety and efficacy.

azathioprine
adalimumab
prednisone
  • 4 views
  • 22 May, 2021
  • 1 location